TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.840
0.00 (0.00%)
At close: Jul 10, 2025, 4:00 PM
1.870
+0.030 (1.63%)
After-hours: Jul 10, 2025, 7:24 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $104.13 million as of July 10, 2025. Its market cap has decreased by -70.56% in one year.
Market Cap
104.13M
Enterprise Value
-50.53M
1-Year Change
-70.56%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $104.13M, a decrease of -71.00%. That is a compound annual growth rate of -26.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 104.13M | -39.38% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |